Table 2.
Correlation Between SCAMP3 and Clinicopathological Characteristics of Glioma Patients
| Variables | Cases | SCAMP3 Expression | P value | |
|---|---|---|---|---|
| (n = 107) | Low (n = 63) | High (n = 44) | ||
| Sex | 0.769 | |||
| Female | 42 | 24 | 18 (42.9%) | |
| Male | 65 | 39 | 26 (40.0%) | |
| Age (years) | 0.176 | |||
| ≤50 | 50 | 26 | 24 (48.0%) | |
| >50 | 57 | 37 | 20 (35.1%) | |
| Tumor Size | 0.011* | |||
| ≤5 cm | 64 | 44 | 20 (31.3%) | |
| >5 cm | 43 | 19 | 24 (55.8%) | |
| WHO Grade | 0.010* | |||
| II | 21 | 16 | 5 (23.8%) | |
| III | 34 | 24 | 10 (29.4%) | |
| IV | 52 | 23 | 29 (55.8%) | |
| KPS Score | 0.609 | |||
| ≤90 | 65 | 37 | 28 (43.1%) | |
| >90 | 42 | 26 | 16 (38.1%) | |
| Resection Pattern | 0.461 | |||
| GTR | 84 | 51 | 33 (39.3%) | |
| STR | 23 | 12 | 11 (47.8%) | |
Note: *P<0.05 by Chi-square test.
Abbreviations: SCAMP3, secretory carrier-associated membrane protein 3; KPS, Karnofsky performance score; GTR, gross total resection; STR, subtotal resection.